Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 14, 2007
Stem Cells Vol. 25 No. 9 September 2007, pp. 2371 -2382
doi:10.1634/stemcells.2007-0225; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0225v1
2007-0225v2
25/9/2371    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, K. R.
Right arrow Articles by Toguchida, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, K. R.
Right arrow Articles by Toguchida, J.

TRANSLATIONAL AND CLINICAL RESEARCH: MESENCHYMAL STEM CELLS SERIES

Expression of the p16INK4A Gene Is Associated Closely with Senescence of Human Mesenchymal Stem Cells and Is Potentially Silenced by DNA Methylation During In Vitro Expansion

Kotaro R. Shibataa,b, Tomoki Aoyamaa, Yasuko Shimaa,b, Kenichi Fukiagea, Seiji Otsukaa, Moritoshi Furua, Yoshiki Kohnoa,b, Kinya Itoa, Shunsuke Fujibayashib, Masashi Neob, Tomitaka Nakayamab, Takashi Nakamurab, Junya Toguchidaa

aInstitute for Frontier Medical Sciences and
bGraduate School of Medicine, Kyoto University, Kyoto, Japan

Key Words. Mesenchymal stem cells • Telomere • Methylation • p16INK4A • Senescence • BMI1

Correspondence: Tomoki Aoyama, M.D., Ph.D., Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan. Telephone: +81-75-751-4107; Fax: +81-75-751-4646; e-mail: blue{at}frontier.kyoto-u.ac.jp

Received March 28, 2007; accepted for publication June 5, 2007.
First published online in STEM CELLS EXPRESS   June 14, 2007.



The precise biological characteristics of human mesenchymal stem cells (hMSCs), including growth regulatory mechanisms, have not yet been defined. Using 29 strains of hMSCs isolated from bone marrow, we have performed extensive analyses of the growth profiles of hMSCs in vitro. All 29 strains stopped proliferating with a mean population doubling (PD) of 28, although there was a considerable difference among strains. The mean telomere restriction fragment length of the cells passaged twice correlated well with the final number of PDs in each strain, suggesting the value of this measurement to be predictive of the growth potential of hMSCs. The expression level of the p16INK4A gene was associated closely with the PD number of each strain (p = .00000001). Most of the p16INK4A-positive cells were Ki67-negative and senescence associated ß-galactosidase-positive, and the suppression of p16INK4A gene expression by small interfering RNA in senescent hMSCs reduced the number of senescent cells and endowed them with the ability to proliferate. Twenty-five of the 29 strains showed a steady gradual increase in the expression of p16INK4A. The remaining four strains (13.8%) showed different profiles, in which DNA methylation in the promoter region occurred in vitro. One of the four strains continued to proliferate for much longer than the others and showed chromosomal aberrations in the later stages. These results indicated p16INK4A to be a key factor in the regulation of hMSC growth, and, most importantly, careful monitoring of DNA methylation should be considered during the culture of hMSCs, particularly when a prolonged and extended propagation is required.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.